Literature DB >> 23149439

Ex vivo organotypic corneal model of acute epithelial herpes simplex virus type I infection.

Oleg Alekseev1, Anh H Tran, Jane Azizkhan-Clifford.   

Abstract

Herpes keratitis is one of the most severe pathologies associated with the herpes simplex virus-type 1 (HSV-1). Herpes keratitis is currently the leading cause of both cornea-derived and infection-associated blindness in the developed world. Typical presentation of herpes keratitis includes infection of the corneal epithelium and sometimes the deeper corneal stroma and endothelium, leading to such permanent corneal pathologies as scarring, thinning, and opacity. Corneal HSV-1 infection is traditionally studied in two types of experimental models. The in vitro model, in which cultured monolayers of corneal epithelial cells are infected in a Petri dish, offers simplicity, high level of replicability, fast experiments, and relatively low costs. On the other hand, the in vivo model, in which animals such as rabbits or mice are inoculated directly in the cornea, offers a highly sophisticated physiological system, but has higher costs, longer experiments, necessary animal care, and a greater degree of variability. In this video article, we provide a detailed demonstration of a new ex vivo model of corneal epithelial HSV-1 infection, which combines the strengths of both the in vitro and the in vivo models. The ex vivo model utilizes intact corneas organotypically maintained in culture and infected with HSV-1. The use of the ex vivo model allows for highly physiologically-based conclusions, yet it is rather inexpensive and requires time commitment comparable to that of the in vitro model.

Entities:  

Mesh:

Year:  2012        PMID: 23149439      PMCID: PMC3514049          DOI: 10.3791/3631

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  9 in total

1.  Corneal organ culture model for assessing epithelial responses to surfactants.

Authors:  K P Xu; X F Li; F S Yu
Journal:  Toxicol Sci       Date:  2000-12       Impact factor: 4.849

Review 2.  Herpes simplex keratitis.

Authors:  Stephen Kaye; Anshoo Choudhary
Journal:  Prog Retin Eye Res       Date:  2006-06-27       Impact factor: 21.198

3.  A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization.

Authors:  D M Foreman; S Pancholi; J Jarvis-Evans; D McLeod; M E Boulton
Journal:  Exp Eye Res       Date:  1996-05       Impact factor: 3.467

4.  In vivo immunofluorescence to diagnose herpes simplex virus keratitis in mice.

Authors:  A Sharma; C Shimeld
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

Review 5.  Human herpes simplex virus keratitis: the pathogenesis revisited.

Authors:  Lies Remeijer; Albert Osterhaus; Georges Verjans
Journal:  Ocul Immunol Inflamm       Date:  2004-12       Impact factor: 3.070

Review 6.  Corneal gene therapy.

Authors:  Eytan A Klausner; Dan Peer; Robert L Chapman; Richard F Multack; Shridhar V Andurkar
Journal:  J Control Release       Date:  2007-07-04       Impact factor: 9.776

7.  Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model.

Authors:  Partha S Bhattacharjee; Donna M Neumann; Timothy P Foster; Christian Clement; Gyanendra Singh; Hilary W Thompson; Herbert E Kaufman; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

8.  Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1 antibodies in an ex vivo model.

Authors:  Elena S Novitskaya; Victoria E McGilligan; Jonathan E Moore; Anant Sharma; Simon J Dean; Tara C B Moore
Journal:  Cornea       Date:  2009-05       Impact factor: 2.651

9.  ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Authors:  William P Halford; Carla Weisend; Jennifer Grace; Mark Soboleski; Daniel J J Carr; John W Balliet; Yumi Imai; Todd P Margolis; Bryan M Gebhardt
Journal:  Virol J       Date:  2006-06-09       Impact factor: 4.099

  9 in total
  17 in total

1.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

2.  The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation.

Authors:  Peter Drevets; Ana Chucair-Elliott; Priyadarsini Shrestha; Jeremy Jinkins; Dimitrios Karamichos; Daniel J J Carr
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-06       Impact factor: 3.117

3.  Establishment and characterization of an air-liquid canine corneal organ culture model to study acute herpes keratitis.

Authors:  Rebecca M Harman; Leen Bussche; Eric C Ledbetter; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

4.  Activation of checkpoint kinase 2 is critical for herpes simplex virus type 1 replication in corneal epithelium.

Authors:  Oleg Alekseev; Vladimir Limonnik; Kelly Donovan; Jane Azizkhan-Clifford
Journal:  Ophthalmic Res       Date:  2014-12-19       Impact factor: 2.892

5.  Nonthermal Dielectric Barrier Discharge (DBD) Plasma Suppresses Herpes Simplex Virus Type 1 (HSV-1) Replication in Corneal Epithelium.

Authors:  Oleg Alekseev; Kelly Donovan; Vladimir Limonnik; Jane Azizkhan-Clifford
Journal:  Transl Vis Sci Technol       Date:  2014-03-27       Impact factor: 3.283

Review 6.  Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Authors:  Katie Bryant-Hudson; Christopher D Conrady; Daniel J J Carr
Journal:  Prog Retin Eye Res       Date:  2013-07-19       Impact factor: 21.198

7.  An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.

Authors:  Paul J Park; Thessicar E Antoine; Asim V Farooq; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-27       Impact factor: 4.799

8.  Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.

Authors:  Oleg Alekseev; Kelly Donovan; Jane Azizkhan-Clifford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-03       Impact factor: 4.799

9.  Establishment of a novel in vitro model of stratified epithelial wound healing with barrier function.

Authors:  Miguel Gonzalez-Andrades; Luis Alonso-Pastor; Jérôme Mauris; Andrea Cruzat; Claes H Dohlman; Pablo Argüeso
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

10.  Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.

Authors:  Satvik R Hadigal; Alex M Agelidis; Ghadah A Karasneh; Thessicar E Antoine; Abraam M Yakoub; Vishnu C Ramani; Ali R Djalilian; Ralph D Sanderson; Deepak Shukla
Journal:  Nat Commun       Date:  2015-04-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.